Affiliation:
1. Tver State Medical University of Minzdrav of Russia
Abstract
In the structure of total mortality, cardiovascular diseases are in the first place in the world. The main and most common reason for this is the incidence of myocardial infarction (MI). The basis of the pathogenesis of MI with ST elevation is persistent and complete thrombotic occlusion of the large epicardial branch of the coronary artery, leading to extensive necrosis of the heart muscle with the development of life-threatening complications, including death, the frequency of which is 8–10 %. The prognosis for MI is influenced by the presence of risk factors, complications, hemodynamic status, polymorbidity, as well as tactics for restoring coronary blood flow. To eliminate acute coronary artery occlusion, conservative treatment is used – thrombolytic therapy, surgical – primary percutaneous intervention, thromboextraction, coronary bypass surgery, as well as their combination. Today, there are scattered and isolated studies characterizing the approach to treatment in patients with MI with ST elevation in various diseases and with polymorbid pathology, the relationship with risk factors and laboratory and instrumental data has not been established, among which predictors of rapid response and death in patients with polymorbid pathology for emergency physicians have not been determined. It can be assumed that the chosen optimal patient management tactics in a specific clinical situation, taking into account the above-mentioned factors, will reduce the development of complications and increase the survival rate of patients with MI.
Publisher
Institute of Cytology and Genetics, SB RAS
Reference41 articles.
1. Drapkina O.M., Samorodskaia I.V., Kakorina E.P. Variability in regional mortality rates. Profilakticheskaya meditsina = The Russian Journal of Preventive Medicine and Public Health. 2019;22(6):28–33. [In Russian]. doi: 10.17116/profmed20192206228
2. Averkov O.V., Duplyakov D.V., Gilyarov M.Yu., Novikova N.A., Shakhnovich R.M., Yakovlev A.N., Abugov S.A., Alekyan B.G., Arkhipov M.V., Barbarash O.L., … Yakushin S.S. 2020 Сlinical practice guidelines for acute ST-segment elevation myocardial infarction. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2020;25(11):251–310. [In Russian]. doi: 10 0.15829/1560-4071-2020-4103
3. Sharafeev A.Z., Bayazitova V.A., Alkhazurov A.I., Khalirakhmanov A.F. Promising drug therapy of reperfusion injury in acute myocardial infarction. Prakticheskaya meditsina = Practical Medicine. 2019;17(2):21–27. [In Russian].
4. Skrypnik D.V., Reztsov R.Yu., Makarycheva O.V., Konovalova E.V., Vasilyeva E.Yu., Shpektor A.V. A modern treatment approach of acute myocardial infarction in patients presenting with ST-segment elevation. Kreativnaya kardiologiya = Creative Cardiology. 2014;(2):5–14. [In Russian].
5. Dolya E.M., Gaffarova A.S. Modern aspects of the choice of the myocardium reperfusion strategy in acute coronary syndrome with st elevation. Tavricheskiy Medico-biologicheskiy vestnik = Tauric MedicoBiological Bulletin. 2018;21(1);196–205. [In Russian].